Literature DB >> 1938748

Pulmonary surfactant will secure free airflow through a narrow tube.

M Y Liu1, L M Wang, E Li, G Enhorning.   

Abstract

Well functioning pulmonary surfactant is necessary to ensure alveolar stability. It is proposed that surfactant is also required to keep the finest cylindrical airways open, thereby securing an unrestricted flow of air to and from the alveoli. If the surfactant is inadequate in quality or quality there is a risk that liquid will accumulate in the most marrow section of the airway and form a blocking column. To study that possibility special glass capillaries were used. The glass capillaries were heated and extended to make a short section very narrow. In the lumen of that section a minute volume (1 microliter) of liquid was deposited, which formed a blocking column. When pressure was raised on one side of the column, it forced the liquid to move away from the narrow section. Pressure dropped to zero as air could pass, and if the liquid column consisted of calf lung surfactant extract (CLSE), pressure remained at zero because a new liquid column did not form. If, on the other hand, the liquid column consisted of saline solution it would repeatedly reform as soon as it had been pressed out of the capillary's narrow section. The same occurred if the CLSE suspension forming the liquid column was very dilute or contained inhibiting proteins. These observations did not require that the capillary consisted of the material glass; they were also noted when the narrow tube was outlined by epithelium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938748     DOI: 10.1152/jappl.1991.71.2.742

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  The effect of viscoelasticity on the stability of a pulmonary airway liquid layer.

Authors:  David Halpern; Hideki Fujioka; James B Grotberg
Journal:  Phys Fluids (1994)       Date:  2010-01-19       Impact factor: 3.521

2.  Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.

Authors:  A van't Veen; J W Mouton; D Gommers; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 3.  A systematic review of the pharmacological approaches against snoring: can we count on the chickens that have hatched?

Authors:  Shyambalaji Achuthan; Bikash Medhi
Journal:  Sleep Breath       Date:  2015-02-14       Impact factor: 2.816

4.  Pulmonary fluid flow challenges for experimental and mathematical modeling.

Authors:  Rachel Levy; David B Hill; M Gregory Forest; James B Grotberg
Journal:  Integr Comp Biol       Date:  2014-08-05       Impact factor: 3.326

5.  Tensiometric and Phase Domain Behavior of Lung Surfactant on Mucus-like Viscoelastic Hydrogels.

Authors:  Daniel M Schenck; Jennifer Fiegel
Journal:  ACS Appl Mater Interfaces       Date:  2016-03-01       Impact factor: 9.229

6.  Liquid plug formation in an airway closure model.

Authors:  F Romanò; H Fujioka; M Muradoglu; J B Grotberg
Journal:  Phys Rev Fluids       Date:  2019-09-24       Impact factor: 2.537

7.  Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea?

Authors:  Liang Shao; Nanfang Li; Xiaoguang Yao; Mulalibieke Heizati; Arikin Abdireim; Yingchun Wang; Zufeiya Abulikemu; Delian Zhang; Guijuan Chang; Ling Zhou; Jing Hong; Yongping Zhang; Jianqiong Kong; Xiangyang Zhang
Journal:  Sleep Breath       Date:  2015-05-08       Impact factor: 2.816

8.  Acute chlorine gas exposure produces transient inflammation and a progressive alteration in surfactant composition with accompanying mechanical dysfunction.

Authors:  Christopher B Massa; Pamela Scott; Elena Abramova; Carol Gardner; Debra L Laskin; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2014-02-25       Impact factor: 4.219

9.  Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.

Authors:  A van 't Veen; J W Mouton; D Gommers; J A Kluytmans; P Dekkers; B Lachmann
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 10.  Pulmonary surfactant therapy.

Authors:  F R Poulain; J A Clements
Journal:  West J Med       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.